Response by Navarese et al to Letters Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials"
- PMID: 33555917
- DOI: 10.1161/CIRCULATIONAHA.120.051630
Response by Navarese et al to Letters Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials"
Comment on
-
Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials.Circulation. 2020 Jul 14;142(2):150-160. doi: 10.1161/CIRCULATIONAHA.120.046786. Epub 2020 May 29. Circulation. 2020. PMID: 32468837 Free PMC article.
-
Letter by Alkhalil and Kuzemczak Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".Circulation. 2021 Feb 9;143(6):e234-e235. doi: 10.1161/CIRCULATIONAHA.120.050967. Epub 2021 Feb 8. Circulation. 2021. PMID: 33555915 No abstract available.
-
Letter by Kessler et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".Circulation. 2021 Feb 9;143(6):e230-e231. doi: 10.1161/CIRCULATIONAHA.120.049650. Epub 2021 Feb 8. Circulation. 2021. PMID: 33555921 No abstract available.
-
Letter by Ferracane et al Regarding Article, "Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials".Circulation. 2021 Feb 9;143(6):e232-e233. doi: 10.1161/CIRCULATIONAHA.120.050472. Epub 2021 Feb 8. Circulation. 2021. PMID: 33555923 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources